meta-analysis
Summary
A meta-analysis is a statistical technique that quantitatively combines results from multiple independent studies addressing the same question to produce a single pooled effect estimate. It sits at the top of the evidence hierarchy (with systematic reviews) and increases statistical power and precision, but is limited by heterogeneity, publication bias, and the quality of the included studies ("garbage in, garbage out").
Detail
**Definition:** Statistical synthesis of data from multiple studies (usually RCTs, but can include cohort/case-control) to generate a pooled estimate of effect. A meta-analysis is usually performed as part of a systematic review (a structured, reproducible literature search with predefined inclusion/exclusion criteria), but a systematic review does not always include a meta-analysis.
**Steps:** 1. Formulate a focused question (PICO: Population, Intervention, Comparison, Outcome). 2. Comprehensive, systematic literature search (multiple databases, grey literature, unpublished data). 3. Apply predefined inclusion/exclusion criteria. 4. Assess study quality and risk of bias (e.g., Cochrane Risk of Bias tool). 5. Extract data and statistically pool results, weighting larger/more precise studies more heavily (inverse-variance weighting). 6. Assess heterogeneity and publication bias; perform sensitivity/subgroup analyses.
**Key concepts:** - **Forest plot:** Displays each study's effect estimate (square, size proportional to weight) with its 95% CI (horizontal line) and the pooled estimate (diamond). Vertical line = null value (RR/OR = 1; mean difference = 0). If the CI or diamond crosses the line of no effect, the result is not statistically significant. - **Funnel plot:** Scatterplot of effect size vs. study precision/size, used to detect publication bias. Symmetric inverted funnel = low bias; asymmetry suggests publication bias (small negative studies missing). - **Heterogeneity:** Variability among studies' results beyond chance. Assessed with Cochran's Q test and the I² statistic (% of variability due to heterogeneity rather than chance; roughly >50% = substantial). - **Fixed-effects model:** Assumes one true underlying effect; differences are due to chance. Used when heterogeneity is low. - **Random-effects model:** Assumes the true effect varies across studies; gives wider CIs. Used when heterogeneity is present.
**Advantages:** - Increased statistical power and precision (narrower CI) - Can detect small effects or effects in subgroups that individual trials were underpowered for - Resolves conflicting results across studies - Generalizability across populations - Can identify gaps in the literature and generate hypotheses
**Limitations:** - Publication bias (positive studies preferentially published) - Heterogeneity in populations, interventions, outcomes, or methodology ("apples and oranges") - "Garbage in, garbage out": pooling low-quality studies yields unreliable results - Selection bias from search strategy or inclusion criteria - Confounding from observational studies - Can be outweighed by a single large, well-designed RCT in some cases
**Board-relevant points:** - Evidence hierarchy (highest to lowest): systematic reviews/meta-analyses of RCTs → individual RCTs → cohort studies → case-control studies → cross-sectional studies → case series/case reports → expert opinion/animal/in vitro studies. - Meta-analysis is not a primary study design; it is a secondary analysis of existing data. - It does not eliminate bias inherent in the underlying studies. - Related terms: Cochrane Collaboration (source of high-quality systematic reviews), PRISMA (reporting guideline for systematic reviews/meta-analyses), intention-to-treat analysis, NNT/NNH, relative risk, odds ratio. - Typical USMLE question stem: "A researcher combines data from 12 randomized trials to estimate the overall effect of a drug on mortality" → meta-analysis. Or: "Which tool is used to assess publication bias?" → funnel plot.
Sources
- First Aid for the USMLE Step 1 – Biostatistics & Epidemiology (Evidence-based medicine section)
- Kaplan USMLE Step 1 Lecture Notes: Behavioral Science & Biostatistics
- Cochrane Handbook for Systematic Reviews of Interventions
- PRISMA 2020 Statement (BMJ 2021;372:n71)
- Gordis Epidemiology, Elsevier
- UWorld Step 1 QBank – Biostatistics
Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.